{"id":"https://openalex.org/W7225412420","doi":"https://doi.org/10.1161/circ.154.suppl_1.15300","title":"Abstract 15300: Warfarin vs. DOACs vs. Antiplatelet Therapy in Non-Valvular Atrial Fibrillation with End-Stage Renal Disease on Dialysis","display_name":"Abstract 15300: Warfarin vs. DOACs vs. Antiplatelet Therapy in Non-Valvular Atrial Fibrillation with End-Stage Renal Disease on Dialysis","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225412420","doi":"https://doi.org/10.1161/circ.154.suppl_1.15300"},"language":"en","primary_location":{"id":"doi:10.1161/circ.154.suppl_1.15300","doi":"https://doi.org/10.1161/circ.154.suppl_1.15300","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.15300","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031070247","display_name":"Keshav Garg","orcid":"https://orcid.org/0000-0003-2175-543X","observed_orcids":["https://orcid.org/0000-0003-2175-543X"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keshav Garg","raw_affiliation_strings":["Dept of Internal Medicine, Univ of Arkansas for Med Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Internal Medicine, Univ of Arkansas for Med Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081904406","display_name":"Ankit Agrawal","orcid":"https://orcid.org/0000-0001-7885-6667","observed_orcids":["https://orcid.org/0000-0001-7885-6667"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ankit Agrawal","raw_affiliation_strings":["Dept of Cardiovascular Medicine, Univ of Arkansas for Med Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Cardiovascular Medicine, Univ of Arkansas for Med Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085181257","display_name":"Nitesh Gautam","orcid":"https://orcid.org/0000-0003-3407-3745","observed_orcids":["https://orcid.org/0000-0003-3407-3745"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitesh Gautam","raw_affiliation_strings":["Dept of Cardiovascular Medicine, Univ of Arkansas for Med Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Cardiovascular Medicine, Univ of Arkansas for Med Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079701464","display_name":"Saumya Nanda","orcid":"https://orcid.org/0000-0002-5754-8849","observed_orcids":["https://orcid.org/0000-0002-5754-8849"]},"institutions":[{"id":"https://openalex.org/I1326872476","display_name":"Maimonides Medical Center","ror":"https://ror.org/00g651r29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1326872476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saumya Nanda","raw_affiliation_strings":["Dept of Internal Medicine, Maimonides Med Cntr, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Internal Medicine, Maimonides Med Cntr, New York, NY","institution_ids":["https://openalex.org/I1326872476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128306453","display_name":"Karim Hoyek","orcid":"https://orcid.org/0009-0002-8486-8466","observed_orcids":["https://orcid.org/0009-0002-8486-8466"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karim Hoyek","raw_affiliation_strings":["Dept of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028893430","display_name":"Aro Daniela Arockiam","orcid":"https://orcid.org/0009-0004-9691-7258","observed_orcids":["https://orcid.org/0009-0004-9691-7258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aro Daniela Arockiam","raw_affiliation_strings":["Dept of Internal Medicine, Unity Health, Searcy, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Internal Medicine, Unity Health, Searcy, AR","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082213090","display_name":"Elio Haroun","orcid":"https://orcid.org/0000-0001-6230-0031","observed_orcids":["https://orcid.org/0000-0001-6230-0031"]},"institutions":[{"id":"https://openalex.org/I4210117499","display_name":"Yale New Haven Health System","ror":"https://ror.org/01s1hsq14","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210117499"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elio Haroun","raw_affiliation_strings":["Dept of Internal Medicine, Yale New-Haven Health System, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Internal Medicine, Yale New-Haven Health System, New Haven, CT","institution_ids":["https://openalex.org/I4210117499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008223164","display_name":"Muhammad Majid","orcid":"https://orcid.org/0000-0002-9353-361X","observed_orcids":["https://orcid.org/0000-0002-9353-361X","https://orcid.org/0009-0002-6806-4345"]},"institutions":[{"id":"https://openalex.org/I2802212778","display_name":"AdventHealth Sebring","ror":"https://ror.org/04r6zx259","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802212778"]},{"id":"https://openalex.org/I4405270336","display_name":"AdventHealth","ror":"https://ror.org/00gqase94","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405270336"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Majid","raw_affiliation_strings":["Dept of Internal Medicine, Advent Health Florida, Sebring, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Internal Medicine, Advent Health Florida, Sebring, FL","institution_ids":["https://openalex.org/I2802212778","https://openalex.org/I4405270336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026454796","display_name":"Yi Wen Becky Liao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800397025","display_name":"Middlemore Hospital","ror":"https://ror.org/055d6gv91","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2800397025","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Yi Wen Becky Liao","raw_affiliation_strings":["Dept of Cardiology, Middlemore Hosp, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Cardiology, Middlemore Hosp, Auckland, New Zealand","institution_ids":["https://openalex.org/I2800397025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062843291","display_name":"Harvey Douglas White","orcid":"https://orcid.org/0000-0001-7712-6750","observed_orcids":["https://orcid.org/0000-0001-7712-6750"]},"institutions":[{"id":"https://openalex.org/I2801418622","display_name":"Auckland City Hospital","ror":"https://ror.org/05e8jge82","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2801418622","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Harvey D White","raw_affiliation_strings":["Green Lane Cardiovascular Service Line, Te Toka Tumai Auckland City Hosp, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Green Lane Cardiovascular Service Line, Te Toka Tumai Auckland City Hosp, Auckland, New Zealand","institution_ids":["https://openalex.org/I2801418622"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5143776781","display_name":"Tom Kai Ming Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801418622","display_name":"Auckland City Hospital","ror":"https://ror.org/05e8jge82","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2801418622","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Tom Kai Ming Wang","raw_affiliation_strings":["Green Lane Cardiovascular Service Line, Te Toka Tumai Auckland City Hosp, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Green Lane Cardiovascular Service Line, Te Toka Tumai Auckland City Hosp, Auckland, New Zealand","institution_ids":["https://openalex.org/I2801418622"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"154","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dialysis","display_name":"dialysis","score":0.953000009059906},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8799999952316284},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":1.0},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.9779999852180481},{"id":"https://openalex.org/keywords/antithrombotic-strategy","display_name":"antithrombotic strategy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/stroke-and-systemic-embolism","display_name":"stroke and systemic embolism","score":0.7940000295639038},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cerebral-infarction","display_name":"cerebral infarction","score":0.7580000162124634},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.47200000286102295},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.6299999952316284},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9836999773979187},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8047000169754028},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.75},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7027000188827515},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6103000044822693},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5385000109672546},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.4961000084877014},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.4325000047683716},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.4269999861717224},{"id":"https://openalex.org/C2779736815","wikidata":"https://www.wikidata.org/wiki/Q1130519","display_name":"valvular heart disease","level":2,"score":0.4077000021934509},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4049000144004822},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.3880999982357025},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.31619998812675476},{"id":"https://openalex.org/C2909112448","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Platelet aggregation inhibitor","level":3,"score":0.3028999865055084},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.29789999127388},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.29580000042915344},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.2777000069618225},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2775000035762787},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.2721000015735626},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.260699987411499},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.2572999894618988},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.25600001215934753},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.2549999952316284}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.154.suppl_1.15300","doi":"https://doi.org/10.1161/circ.154.suppl_1.15300","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.15300","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389786529","https://openalex.org/W4386797065","https://openalex.org/W7162257395","https://openalex.org/W2939256306","https://openalex.org/W4388594898","https://openalex.org/W4394762668","https://openalex.org/W4388595375","https://openalex.org/W4404360099","https://openalex.org/W4386219707","https://openalex.org/W3098526172"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,157,170],"optimal":[2],"antithrombotic":[3],"strategy":[4],"for":[5],"non-valvular":[6],"atrial":[7],"fibrillation":[8],"(NVAF)":[9],"in":[10,42,64,75,218,348],"patients":[11,43,66,87,289],"with":[12,44,46,56,61,67,90,97,276,290,300,314,317,362],"end-stage":[13],"renal":[14],"disease":[15,100],"(ESRD)":[16],"on":[17,48,69,94,292],"dialysis":[18],"remains":[19],"uncertain.":[20],"Therefore,":[21],"we":[22,85],"aimed":[23],"to":[24,333,359],"evaluate":[25],"and":[26,31,39,52,92,129,154,167,184,251,296,324,330,351],"compare":[27],"the":[28,80,305,339],"real-world":[29],"efficacy":[30,159,219,329],"safety":[32,172,229,331],"of":[33,164,177,304,307,341],"direct":[34],"oral":[35,342],"anticoagulants":[36],"(DOACs),":[37],"warfarin,":[38,360],"antiplatelet":[40,62,125,133,238,263,315,345],"agents":[41],"NVAF":[45,65,91,288],"ESRD":[47,68,93,291],"dialysis.":[49,95],"Hypothesis:":[50],"DOACs":[51,297,325,353],"warfarin":[53,116,123,295],"are":[54],"associated":[55,299],"superior":[57],"thromboembolic":[58],"protection":[59],"compared":[60,313],"therapy":[63,346],"dialysis,":[70,293],"without":[71],"a":[72,162,175,192,240,265,356],"significant":[73,216],"increase":[74],"bleeding":[76,179,253,278,321],"risk.":[77,322],"Methods:":[78],"Using":[79],"TriNetX":[81],"U.S.":[82],"Collaborative":[83],"Network,":[84],"identified":[86],"(\u226518":[88],"years)":[89],"Patients":[96],"valvular":[98],"heart":[99,103,145],"or":[101,228,310,319],"prosthetic":[102],"valves":[104],"were":[105,113,189,205,298],"excluded.":[106],"Three":[107],"pairwise":[108],"propensity":[109],"score-matched":[110],"(PSM)":[111],"analyses":[112],"performed:":[114],"(1)":[115],"vs.":[117,124,132,212,237,262],"DOAC":[118,131,213,261],"(n=2,286":[119],"per":[120,127,135],"cohort),":[121,128],"(2)":[122],"(n=2,129":[126],"(3)":[130],"(n=4,884":[134],"cohort).":[136],"PSM":[137],"covariates":[138,204],"included":[139],"age,":[140],"sex,":[141],"race/ethnicity,":[142],"diabetes,":[143],"hypertension,":[144],"failure,":[146],"atherosclerosis,":[147],"liver":[148],"disease,":[149],"tobacco":[150],"use,":[151],"alcohol-related":[152],"disorders,":[153],"NSAID":[155],"use.":[156],"primary":[158,171,243,268],"outcome":[160,173],"was":[161,174],"composite":[163,176,306],"cerebral":[165],"infarction":[166],"systemic":[168,311],"embolism.":[169],"major":[178],"events,":[180],"including":[181],"intracranial,":[182],"gastrointestinal,":[183],"other":[185],"hemorrhagic":[186],"complications.":[187],"Outcomes":[188],"assessed":[190],"at":[191],"5-year":[193],"follow-up":[194],"period":[195],"using":[196],"Kaplan-Meier":[197],"survival":[198],"analysis.":[199],"Results:":[200],"After":[201],"PSM,":[202],"baseline":[203],"well":[206],"balanced":[207],"(all":[208],"SMD":[209],"<0.08).":[210],"Warfarin":[211,236,323],"showed":[214,264],"no":[215],"difference":[217],"(Hazard":[220],"ratio":[221],"(HR)":[222],"0.93;":[223],"95%":[224,232,247,257,272,282],"CI":[225,233,248,258,273,283],"0.64-1.36;":[226],"p=0.721)":[227],"(HR":[230,245,255,270,280],"0.86;":[231],"0.69-1.09;":[234],"p=0.216).":[235],"demonstrated":[239,326],"significantly":[241,266,301],"lower":[242,252,267,302,320],"endpoint":[244,269],"0.48;":[246],"0.36-0.66;":[249],"p<0.001)":[250],"risk":[254,279],"0.80;":[256],"0.65-0.99;":[259],"p=0.043).":[260],"0.58;":[271],"0.45-0.74;":[274],"p<0.001),":[275],"comparable":[277,318],"0.94;":[281],"0.80-1.11;":[284],"p=0.483).":[285],"Conclusions:":[286],"In":[287],"both":[294],"rates":[303],"ischemic":[308],"stroke":[309],"embolism":[312],"therapy,":[316],"similar":[327],"long-term":[328],"profiles":[332],"each":[334],"other.":[335],"These":[336],"findings":[337],"support":[338],"use":[340],"anticoagulation":[343],"over":[344],"alone":[347],"this":[349],"population":[350],"suggest":[352],"may":[354],"be":[355],"reasonable":[357],"alternative":[358],"consistent":[361],"evolving":[363],"guideline":[364],"recommendations.":[365]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}